AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18371049 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipolotion with 0.5% coriander oil
Number of subjects: 40
Study 18371049 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone (1.0%)
Number of subjects: 40
Study 18371049 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 40
Study 18371049 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipolotion with 1.0% coriander oil
Number of subjects: 40
Study 16039873 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated estrogen-progestin (E+P)
Number of subjects: 2763
Study 16039873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2763
Study 16039873 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline serum UA levels
Number of subjects: 2763
Study 16039873 — intervention group
Group type: EXPERIMENTAL
Intervention: On-study change in serum UA level
Number of subjects: 2763
Study 14505813 — intervention group
Group type: EXPERIMENTAL
Intervention: 14 g/day fish oil (HFO)
Number of subjects: 30
Study 14505813 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 g/day of both safflower oil and fish oil (LFO)
Number of subjects: 30
Study 14505813 — intervention group
Group type: COMPARATOR
Intervention: 14 g/day safflower oil (SO)
Number of subjects: 30
Study 11131946 — intervention group
Group type: EXPERIMENTAL
Intervention: High defensive subjects
Number of subjects: 16
Study 11131946 — intervention group
Group type: COMPARATOR
Intervention: Low defensive subjects
Number of subjects: 16
Study 8805993 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate (1600 mg/day, orally)
Number of subjects: 67
Study 8805993 — intervention group
Group type: COMPARATOR
Intervention: Control (no clodronate treatment)
Number of subjects: 67
Study 1289954 — intervention group
Group type: EXPERIMENTAL
Intervention: P‐30 composite resin
Number of subjects: 27
Study 1289954 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisfil‐P composite resin
Number of subjects: 27
Study 1289954 — intervention group
Group type: COMPARATOR
Intervention: Dispersalloy amalgam
Number of subjects: 27
Study 1289954 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite resin restorations in molars
Number of subjects: 27
Study 1289954 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately sized composite resin restorations
Number of subjects: 27
Study 1289954 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite resin with porous strontium glass filler
Number of subjects: 27
Study 1289954 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite resin with zinc glass filler
Number of subjects: 27
Study 1289954 — intervention group
Group type: EXPERIMENTAL
Intervention: Unpolished amalgam
Number of subjects: 27
Study 6397863 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen sodium (1100 mg daily)
Number of subjects: 217
Study 6397863 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefenamic acid (1500 mg daily)
Number of subjects: 217
Study 31257127 — intervention group
Group type: EXPERIMENTAL
Intervention: Cases without HIV infection and with positive chest x-rays
Number of subjects: 1769
Study 31257127 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood cultures
Number of subjects: 1769
Study 31257127 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of pathogens in NP-OP specimens
Number of subjects: 1769
Study 31257127 — intervention group
Group type: EXPERIMENTAL
Intervention: Aetiology analysis
Number of subjects: 1769
Study 31257127 — intervention group
Group type: EXPERIMENTAL
Intervention: Very severe pneumonia cases
Number of subjects: 1769
Study 31257127 — intervention group
Group type: EXPERIMENTAL
Intervention: RSV
Number of subjects: 1769
Study 31257127 — intervention group
Group type: EXPERIMENTAL
Intervention: Aetiological distribution
Number of subjects: 1769
Study 31257127 — intervention group
Group type: EXPERIMENTAL
Intervention: Differences in aetiological fraction by age and severity
Number of subjects: 1769
Study 31257127 — intervention group
Group type: EXPERIMENTAL
Intervention: Leading ten pathogens
Number of subjects: 1769
Study 29941028 — intervention group
Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training (HIIT) - 14 exercise sessions on a stationary cycle ergometer over 4-6 weeks, starting with 10 repeated 1-min blocks of intense exercise, progressing to 5 2-min intervals of high intensity exercise.
Number of subjects: 0
Study 29941028 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study 27329438 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of intravenous tranexamic acid (TXA)
Number of subjects: 0
Study 27329438 — intervention group
Group type: COMPARATOR
Intervention: Intravenous saline (placebo)
Number of subjects: 0
Study 23564447 — intervention group
Group type: EXPERIMENTAL
Intervention: Myocardial contrast echocardiography (MCE) and low-dose dobutamine stress echocardiography (LD-DSE) in Group B (n=27)
Number of subjects: 53
Study 23564447 — intervention group
Group type: COMPARATOR
Intervention: Myocardial contrast echocardiography (MCE) and low-dose dobutamine stress echocardiography (LD-DSE) in Group A (n=26)
Number of subjects: 53
Study 22440854 — intervention group
Group type: EXPERIMENTAL
Intervention: High polyphenol content olive oil (HPC: 366 mg/kg)
Number of subjects: 18
Study 22440854 — intervention group
Group type: COMPARATOR
Intervention: Low polyphenol content olive oil (LPC: 2.7 mg/kg)
Number of subjects: 18
Study 20144692 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency rTMS over the right DLPFC (140 s x 1 Hz) followed by controlateral sham (unilateral group, n=20)
Number of subjects: 60
Study 20144692 — intervention group
Group type: EXPERIMENTAL
Intervention: Low frequency right DLPFC rTMS followed by left DLPFC high frequency rTMS (5 s x 10 Hz) (bilateral group, n=20)
Number of subjects: 60
Study 20144692 — intervention group
Group type: COMPARATOR
Intervention: Bilateral sham (sham group, n=20)
Number of subjects: 60
Study 17294383 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed combination of bimatoprost 0.03%/timolol 0.5%
Number of subjects: 445
Study 17294383 — intervention group
Group type: COMPARATOR
Intervention: Non-fixed combination treatment
Number of subjects: 445
Study 17294383 — intervention group
Group type: COMPARATOR
Intervention: Bimatoprost alone
Number of subjects: 445
Study 17060584 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic 22-gauge needle
Number of subjects: 58
Study 17060584 — intervention group
Group type: COMPARATOR
Intervention: Traumatic 22-gauge needle
Number of subjects: 58
Study 12714816 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured at admission, 24 hours, 15 days, and 30 days after admission.
Number of subjects: 50
Study 12714816 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) levels measured at admission, 24 hours, 15 days, and 30 days after admission.
Number of subjects: 50
Study 12714816 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of PCT and CRP sensitivity and specificity.
Number of subjects: 50
Study 12714816 — intervention group
Group type: EXPERIMENTAL
Intervention: PCT as a prognostic indicator for valve replacement and response to medical treatment.
Number of subjects: 50
Study 12714816 — intervention group
Group type: EXPERIMENTAL
Intervention: PCT levels to guide antimicrobial therapy before culture results.
Number of subjects: 50
Study 10588312 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg orally once daily for 5 days
Number of subjects: 750
Study 10588312 — intervention group
Group type: COMPARATOR
Intervention: Clarithromycin 500 mg orally twice daily for 7 days
Number of subjects: 750
Study 8629205 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper gastrointestinal endoscopy
Number of subjects: 30
Study 8629205 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic thermal therapy (multipolar electrocautery or heater probe) and injection therapy
Number of subjects: 30
Study 8629205 — intervention group
Group type: COMPARATOR
Intervention: Urgent surgical intervention
Number of subjects: 30
Study 1991216 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg triamcinolone
Number of subjects: 0
Study 1991216 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg hydrocortisone
Number of subjects: 0
Study 1991216 — intervention group
Group type: COMPARATOR
Intervention: 2 ml 1% lignocaine
Number of subjects: 0
Study 1991216 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg triamcinolone
Number of subjects: 0
Study 6340813 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural prostaglandin E2 tablets
Number of subjects: 202
Study 6340813 — intervention group
Group type: COMPARATOR
Intervention: Synthetic prostaglandin E2 tablets
Number of subjects: 202
Study 31957252 — intervention group
Group type: EXPERIMENTAL
Intervention: Smelling amniotic fluid for 15 minutes before, during, and after peripheral cannulation
Number of subjects: 61
Study 31957252 — intervention group
Group type: COMPARATOR
Intervention: Routine care during peripheral cannulation
Number of subjects: 61
Study 31957252 — intervention group
Group type: EXPERIMENTAL
Intervention: Smelling amniotic fluid
Number of subjects: 61
Study 31957252 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 61
Study 30888080 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher-delivered classroom lesson about sexual health
Number of subjects: 168
Study 30888080 — intervention group
Group type: EXPERIMENTAL
Intervention: Information materials about sexual health
Number of subjects: 168
Study 30888080 — intervention group
Group type: EXPERIMENTAL
Intervention: Free condom distribution in school corridors
Number of subjects: 168
Study 28624695 — intervention group
Group type: EXPERIMENTAL
Intervention: S49076 (600 mg qd)
Number of subjects: 103
Study 28624695 — intervention group
Group type: EXPERIMENTAL
Intervention: S49076 (various doses from 15 to 900 mg)
Number of subjects: 103
Study 27382587 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS group (6 text messages a week for three months)
Number of subjects: 123
Study 27382587 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder cards group (trained in how and in what order to use their cards)
Number of subjects: 123
Study 27382587 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 123
Study 23963731 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM) 750 mg administered in one week
Number of subjects: 2584
Study 23963731 — intervention group
Group type: COMPARATOR
Intervention: Iron sucrose 200 mg administered in up to five infusions in 14 days
Number of subjects: 2584
Study 23963731 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM)
Number of subjects: 2584
Study 22198902 — intervention group
Group type: EXPERIMENTAL
Intervention: OMRON M6
Number of subjects: 503
Study 22198902 — intervention group
Group type: EXPERIMENTAL
Intervention: Microlife BP A200 Plus
Number of subjects: 503
Study 19615757 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenia group
Number of subjects: 60
Study 19615757 — intervention group
Group type: COMPARATOR
Intervention: Non‐patient comparison subjects
Number of subjects: 60
Study 17243646 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS monitoring for sedation
Number of subjects: 18
Study 17243646 — intervention group
Group type: COMPARATOR
Intervention: Ramsay score monitoring for sedation
Number of subjects: 18
Study 15124080 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of Isatis tinctoria extracts during the ICD eliciting phase
Number of subjects: 20
Study 15124080 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of tryptanthrin during the ICD eliciting phase
Number of subjects: 20
Study 15124080 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment after the eliciting phase
Number of subjects: 20
Study 15124080 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of test substances in the UVB erythema model
Number of subjects: 20
Study 11350435 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic hernia repair
Number of subjects: 928
Study 11350435 — intervention group
Group type: COMPARATOR
Intervention: Open hernia repair
Number of subjects: 928
Study 9045315 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 0
Study 8174444 — intervention group
Group type: EXPERIMENTAL
Intervention: High-monounsaturated fat (HM) diet
Number of subjects: 10
Study 8174444 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate (CHO) diet
Number of subjects: 10
Study 3511207 — intervention group
Group type: EXPERIMENTAL
Intervention: Orally administered arginine free base 1 to 2 mmol/kg/day for 2 months (n = 13)
Number of subjects: 46
Study 3511207 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group (n = 12)
Number of subjects: 46
Study 3511207 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (hyperammonemic and normoammonemic)
Number of subjects: 46
Study 31386891 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg EMEND® capsules
Number of subjects: 0
Study 31386891 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mg EMEND® capsules
Number of subjects: 0
Study 31386891 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro experiments with native surfactants
Number of subjects: 0
Study 31386891 — intervention group
Group type: EXPERIMENTAL
Intervention: Parameter Sensitivity Analysis (PSA)
Number of subjects: 0
Study 31386891 — intervention group
Group type: EXPERIMENTAL
Intervention: Nano-sizing aprepitant
Number of subjects: 0
Study 28753822 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted radical prostatectomy (RARP)
Number of subjects: 120
Study 28753822 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic radical prostatectomy (LRP)
Number of subjects: 120
Study 24401221 — intervention group
Group type: EXPERIMENTAL
Intervention: RSV20/EZE10
Number of subjects: 833
Study 24401221 — intervention group
Group type: EXPERIMENTAL
Intervention: RSV10/EZE10
Number of subjects: 833
Study 24401221 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (RSV10/EZE10 or RSV20/EZE10)
Number of subjects: 833
Study 24401221 — intervention group
Group type: COMPARATOR
Intervention: Statin monotherapy
Number of subjects: 833
Study 24401221 — intervention group
Group type: COMPARATOR
Intervention: Ezetimibe
Number of subjects: 833
Study 24401221 — intervention group
Group type: COMPARATOR
Intervention: Rosuvastatin/ezetimibe and simvastatin/ezetimibe combinations
Number of subjects: 833
Study 23919671 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person navigator intervention
Number of subjects: 0
Study 23919671 — intervention group
Group type: COMPARATOR
Intervention: Informational pamphlet control
Number of subjects: 0
Study 22254119 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea (GT) + water
Number of subjects: 18
Study 22254119 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL) + water
Number of subjects: 18
Study 22254119 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea (GT) + 3.5 MP
Number of subjects: 18
Study 22254119 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL) + 3.5 MP
Number of subjects: 18
Study 22254119 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea (GT) + 15 MP
Number of subjects: 18
Study 22254119 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL) + 15 MP
Number of subjects: 18
Study 18549436 — intervention group
Group type: COMPARATOR
Intervention: Basic Developmental Care (standardized nests and incubator covers)
Number of subjects: 264
Study 18549436 — intervention group
Group type: COMPARATOR
Intervention: Newborn Individualized Developmental Care and Assessment Program (NIDCAP)
Number of subjects: 264
Study 17209488 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone 10 mg
Number of subjects: 55
Study 17209488 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 14593853 — intervention group
Group type: EXPERIMENTAL
Intervention: Bad medical news (BN)
Number of subjects: 25
Study 14593853 — intervention group
Group type: EXPERIMENTAL
Intervention: Good medical news (GN)
Number of subjects: 25
Study 14593853 — intervention group
Group type: COMPARATOR
Intervention: Control (reading magazines)
Number of subjects: 25
Study 10882628 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebendazole (200 mg twice a day for 10 days)
Number of subjects: 46
Study 10882628 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiabendazole (25 mg/kg twice a day for 10 days)
Number of subjects: 46
Study 10882628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 10882628 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (400 mg initially, then 200 mg daily for 10 days)
Number of subjects: 46
Study 10882628 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiabendazole and Mebendazole
Number of subjects: 46
Study 8936542 — intervention group
Group type: COMPARATOR
Intervention: Succinylcholine 1 mg.kg‐1
Number of subjects: 30
Study 8936542 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 0.16 mg.kg‐1 and Mivacurium 0.2 mg.kg‐1 (V2M2)
Number of subjects: 30
Study 8936542 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 0.08 mg.kg‐1 and Mivacurium 0.1 mg.kg‐1 (V1M1)
Number of subjects: 30
Study 1406180 — intervention group
Group type: EXPERIMENTAL
Intervention: 7% carbohydrate‐electrolyte drink (CE)
Number of subjects: 8
Study 1406180 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 8
Study 7015541 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 17
Study 7015541 — intervention group
Group type: COMPARATOR
Intervention: Sulindac
Number of subjects: 17
Study 30980220 — intervention group
Group type: EXPERIMENTAL
Intervention: Lions Quest Skills for Adolescence (LQSFA) program
Number of subjects: 5196
Study 30980220 — intervention group
Group type: COMPARATOR
Intervention: Regular curriculum (control group)
Number of subjects: 5196
Study 26940798 — intervention group
Group type: EXPERIMENTAL
Intervention: Asynchronous video application on a mobile device
Number of subjects: 51
Study 26940798 — intervention group
Group type: COMPARATOR
Intervention: Traditional outpatient physical therapy
Number of subjects: 51
Study 25722977 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm, humidified CO2 insufflation
Number of subjects: 97
Study 25722977 — intervention group
Group type: COMPARATOR
Intervention: Cold‐dry CO2 insufflation
Number of subjects: 97
Study 25608899 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 µg/d mNGF by intramuscular injection for two courses (4 weeks for each course) with a 15-day interval
Number of subjects: 64
Study 25608899 — intervention group
Group type: COMPARATOR
Intervention: Salvia miltiorrhiza Bunge and deproteinized extract of calf blood, methylcobalamin tablets, and vitamin B6
Number of subjects: 64
Study 21095214 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 21
Study 21095214 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 19687767 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg sublingual testosterone
Number of subjects: 0
Study 19687767 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17050661 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0
Study 17050661 — intervention group
Group type: COMPARATOR
Intervention: Lithium
Number of subjects: 0
Study 16488712 — intervention group
Group type: COMPARATOR
Intervention: Lymph node sampling
Number of subjects: 1023
Study 16488712 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymph node dissection
Number of subjects: 1023
Study 12562651 — intervention group
Group type: EXPERIMENTAL
Intervention: GEM (1000 mg/m(2)) on days 1 and 8 and CBDCA (AUC 5 mg.min/ml) on day 1, 4 h before GEM (arm A)
Number of subjects: 88
Study 12562651 — intervention group
Group type: EXPERIMENTAL
Intervention: GEM on days 1 and 8 and CBDCA on day 2 (arm C)
Number of subjects: 88
Study 12562651 — intervention group
Group type: EXPERIMENTAL
Intervention: GEM on days 2 and 9 and CBDCA on day 1 (arm D)
Number of subjects: 88
Study 12562651 — intervention group
Group type: EXPERIMENTAL
Intervention: GEM (1000 mg/m(2)) on days 1 and 8 and CBDCA (AUC 5 mg.min/ml) on day 1, 4 h after GEM (arm B)
Number of subjects: 88
Study 12562651 — intervention group
Group type: EXPERIMENTAL
Intervention: CBDCA given before GEM
Number of subjects: 88
Study 12562651 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 88
Study 10232716 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.3 MAC sevoflurane/N2O
Number of subjects: 24
Study 10232716 — intervention group
Group type: COMPARATOR
Intervention: equi-MAC sevoflurane
Number of subjects: 24
Study 8694085 — intervention group
Group type: EXPERIMENTAL
Intervention: Rimexolone 1% ophthalmic suspension
Number of subjects: 0
Study 8694085 — intervention group
Group type: COMPARATOR
Intervention: 1% prednisolone acetate
Number of subjects: 0
Study 2007323 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalmefene 25 mg orally
Number of subjects: 6
Study 2007323 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalmefene 50 mg orally
Number of subjects: 6
Study 2007323 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalmefene 100 mg orally
Number of subjects: 6
Study 2007323 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 15 mg intramuscularly
Number of subjects: 6
Study 2007323 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 30 mg intramuscularly
Number of subjects: 6
Study 2007323 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 7097818 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver sulfadiazine
Number of subjects: 0
Study 7097818 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 0
Study 29175416 — intervention group
Group type: EXPERIMENTAL
Intervention: Autofluorescence-guided surgery (AF)
Number of subjects: 36
Study 29175416 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgery (non-AF)
Number of subjects: 36
Study 28003205 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g freeze-dried strawberry powder added to a high-fat meal (50 g total fat)
Number of subjects: 30
Study 28003205 — intervention group
Group type: COMPARATOR
Intervention: Control meal (high-fat meal without strawberry powder)
Number of subjects: 30
Study 28003205 — intervention group
Group type: EXPERIMENTAL
Intervention: Both meals (strawberry and control)
Number of subjects: 30
Study 23714235 — intervention group
Group type: COMPARATOR
Intervention: Biphasic calcium phosphate (BCP) alone
Number of subjects: 8